CureVac is a global biopharmaceutical company with more than 20 years of experience in developing the mRNA technology for medical purposes.
CureVac
Biotech company
CureVac N.V. is a German biopharmaceutical company. It develops therapies based on messenger RNA. Headquartered in Tübingen, Germany, the company was founded in 2000 by Ingmar Hoerr, Steve Pascolo, Florian von der Mulbe, Günther Jung, and... Wikipedia
CEO: Alexander Zehnder (Apr 2023–)
Founders: Ingmar Hoerr, Steve Pascolo, Günther Jung, and more
CFO: Pierre Kemula
Headquarters: Tübingen, Germany
Date founded: 2000
Number of employees: < 700
Show more
Show less
People also ask
Does CureVac have a COVID vaccine?
How many employees does CureVac have?
Where is CureVac located?
Following our encouraging interim Phase 2 data in our Seasonal Influenza Program, we've started a new Phase 2 study to assess targeted optimizations of multivalent vaccine candidate for improved immune responses against the influenza B strain. Read more: www.curevac.com/en/c…
CureVac N.V. is a German biopharmaceutical company. It develops therapies based on messenger RNA (mRNA). Headquartered in Tübingen, Germany, the company was ...
CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic ...
Feb 3, 2021 · This collaboration will build on CureVac's first generation COVID-19 vaccine candidate CVnCoV, which is currently in Phase 2b/3 clinical trial ...